Bioventus Inc. (BVS)

NASDAQ: BVS · Real-Time Price · USD

7.26

-0.05 (-0.68%)

At close: May 01, 2025, 3:59 PM

7.05

-2.96%

Pre-market: May 02, 2025, 04:22 AM EDT

Bioventus Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	n/a	-121.2M	-144.65M	9.59M	14.72M	8.11M	4.44M
Depreciation & Amortization	n/a	57.37M	55.4M	34.88M	28.64M	30.32M	29.24M
Stock-Based Compensation	n/a	2.72M	17.59M	19.84M	10.1M	n/a	14.32M
Other Working Capital	-2.52M	-13.24M	-14.53M	-16.46M	15.31M	-3.88M	-422K
Other Non-Cash Items	38.8M	82.01M	119.32M	-31.56M	3.02M	16.2M	-5.59M
Deferred Income Tax	n/a	-2.38M	-46.66M	-9.76M	n/a	-348K	-79K
Change in Working Capital	n/a	-3.18M	-14.53M	n/a	15.31M	-13.57M	2.85M
Operating Cash Flow	38.8M	15.34M	-13.54M	22.99M	71.8M	40.71M	45.19M
Capital Expenditures	-1.72M	-7.36M	-10.04M	-13.52M	-20.67M	-8.34M	-6.06M
Cash Acquisitions	n/a	34.67M	n/a	-262.87M	n/a	430K	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	430K	n/a
Other Investing Acitivies	24.68M	-11.51M	-106.39M	-7.37M	-3.92M	-6.43M	-40K
Investing Cash Flow	22.96M	15.81M	-116.44M	-283.76M	-20.5M	-7.91M	-6.1M
Debt Repayment	-59.58M	-23.26M	59.62M	166.2M	-10M	-1.37M	-5.25M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	-367K	-19.89M	-9.14M	-7.85M
Other Financial Acitivies	2.56M	-4.17M	-3.37M	-37K	317K	-448K	-160K
Financial Cash Flow	-54.58M	-26.65M	62.08M	273.37M	-29.57M	-10.95M	-13.26M
Net Cash Flow	4.62M	5.13M	-67.38M	12.37M	22.32M	21.75M	25.67M
Free Cash Flow	37.79M	7.98M	-25.06M	15.62M	51.13M	32.37M	39.13M